A Sampling of Clips for
January 15, 2003
*
UCSD faculty and staff may obtain a copy of an article by e-mailing
the University
Communications Office
FDA review
deals blow to TKT drug
Boston Globe, Jan. 15, P. 1 –
A Food and Drug Administration panel may have dashed Transkaryotic
Therapies’ chances of ever marketing its drug, Replagal,
used to treat a rare inherited disorder known as Fabry disease.
(Quotes Jerry A. Schneider, a panel member
and Dean of Academic Affairs at UCSD).
http://www.boston.com/dailyglobe2/015/business/FDA_review_deals_blow_to_TKT_drug+.shtml
Poet: On
to life’s next verse
Sacramento Bee, Jan. 15 – UCSD
literature professor Quincy Troupe spoke candidly
about his life since he resigned as California’s first
poet laureate after it was reported that he had falsely claimed
he earned a college degree.
http://www.sacbee.com/content/lifestyle/story/5892963p-6856308c.html
Universities,
colleges face new cuts, fee increases
Copley News Service, Jan. 14 -- California’s
public universities and colleges would be hit with additional
funding cuts and student-fee increases in Gov. Gray Davis’
proposed 2003-04 budget. UCSD officials said
they are particularly concerned about the proposal to cut 10
percent in research funding, which was decreased in the midyear
budget revision, and the 20 percent cut in student services,
which include intramural sports in the UC system.
*
No link available online.
State sees
its ranking in Medicare arena drop
San Diego Union Tribune, Jan. 15 –
California’s ranking among states in treating Medicare
patients has dropped from 39th to 44th during the past two years,
according to a national report released yesterday. (Quotes Richard
Kronick, professor of UCSD’s
department of Family and Preventive Medicine).
http://www.signonsandiego.com/news/uniontrib/wed/news/news_1n15quality.html
Clonaid
it's not
San Diego Daily Transcript, Jan. 15
-- Speakers at the Salk Institute’s "Taking the Lead:
California Advances in Stem Cell Research" forum said that
California can be a center for stem cell research with adequate
funding and supportive legislation. (Quotes Larry Goldstein,
UCSD professor of cellular and molecular medicine).
*
No link available online.
